Abstract
The technology of screen-printed electrodes (SPEs) in biosensor development has received much consideration. Their versatility, miniaturized size and the possibility of connecting them to portable instrumentation make possible highly specific on-site determination of several drugs. This review highlights the recently developed strategies toward immobilization of different biological molecules on disposable electrodes for the sensitive and selective analysis of drugs. Thus, enzyme modified SPEs, DNA modified SPEs and immunosensors based on SPEs are overviewed.
Keywords: Screen-printed electrodes, enzyme biosensors, affinity biosensors, drugs.
Current Pharmaceutical Analysis
Title:Screen-Printed Biosensors in Drug Analysis
Volume: 13 Issue: 2
Author(s): Maria A. Alonso-Lomillo and Olga Dominguez-Renedo
Affiliation:
Keywords: Screen-printed electrodes, enzyme biosensors, affinity biosensors, drugs.
Abstract: The technology of screen-printed electrodes (SPEs) in biosensor development has received much consideration. Their versatility, miniaturized size and the possibility of connecting them to portable instrumentation make possible highly specific on-site determination of several drugs. This review highlights the recently developed strategies toward immobilization of different biological molecules on disposable electrodes for the sensitive and selective analysis of drugs. Thus, enzyme modified SPEs, DNA modified SPEs and immunosensors based on SPEs are overviewed.
Export Options
About this article
Cite this article as:
Alonso-Lomillo A. Maria and Dominguez-Renedo Olga, Screen-Printed Biosensors in Drug Analysis, Current Pharmaceutical Analysis 2017; 13(2) . https://dx.doi.org/10.2174/1573412912666160922112628
DOI https://dx.doi.org/10.2174/1573412912666160922112628 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurological Disorders in Mice Lacking Glycogenes that are Mainly Expressed in Brain
CNS & Neurological Disorders - Drug Targets Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment
Current Drug Targets - Inflammation & Allergy GABAA Receptors, Anesthetics and Anticonvulsants in Brain Development
CNS & Neurological Disorders - Drug Targets Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Research Review: Childhood Maltreatment and Executive Functioning During Adolescence
Adolescent Psychiatry Synthesis, Anticonvulsant Evaluation of 2,3,4,5-Tetrahydro-7-alkoxy-1H-2-benzazepin-1-ones
Letters in Drug Design & Discovery Epileptogenicity and Epileptic Activity: Mechanisms in an Invertebrate Model Nervous System
Current Drug Targets Editorial (Thematic Issue: The Activity of Products From Cnidaria: A Therapeutic Tool in Neurological Diseases? Part II)
Central Nervous System Agents in Medicinal Chemistry The Non-ABC Drug Transporter RLIP76 (RALBP-1) Plays a Major Role in the Mechanisms of Drug Resistance
Current Drug Metabolism On Some Physiological Aspects of Ethanol Repercussion on Neural and Cardiorenal Functions
Central Nervous System Agents in Medicinal Chemistry Antiepileptogenic Effect of Retinoic Acid
Current Neuropharmacology SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications
Pharmaceutical Nanotechnology Sestrins: A New Kid for Stroke Treatment?
Current Drug Delivery Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides
Current Drug Targets Could Hippocampal Neurogenesis be a Future Drug Target for Treating Temporal Lobe Epilepsy?
CNS & Neurological Disorders - Drug Targets Flavonoids as Natural Inhibitors of Jack Bean Urease Enzyme
Letters in Drug Design & Discovery Dysiherbaine: A New Generation of Excitatory Amino Acids of Marine Origin
Central Nervous System Agents in Medicinal Chemistry Lexical Characterisation of Bio-Ontologies by the Inspection of Regularities in Labels
Current Bioinformatics Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Current Drug Abuse Reviews